HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fumitaka Suzuki Selected Research

Chronic Hepatitis B

1/2015Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection.
6/2014Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.
3/2014Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up.
3/2014Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B.
1/2014Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir.
8/2013Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study.
8/2013Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver disease.
9/2012Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.
9/2012Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.
7/2012Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Fumitaka Suzuki Research Topics

Disease

61Infection
07/2015 - 01/2002
51Chronic Hepatitis C
07/2015 - 01/2002
47Chronic Hepatitis B
01/2015 - 01/2002
39Hepatitis B
04/2015 - 01/2002
37Hepatocellular Carcinoma (Hepatoma)
09/2015 - 01/2003
36Fibrosis (Cirrhosis)
10/2015 - 01/2002
27Hepatitis
01/2014 - 01/2002
19Liver Cirrhosis (Hepatic Cirrhosis)
08/2013 - 01/2002
17Chronic Hepatitis (Chronic Active Hepatitis)
03/2014 - 01/2003
11Neoplasms (Cancer)
09/2013 - 06/2004
11Liver Diseases (Liver Disease)
03/2012 - 01/2002
10Hepatitis C
07/2013 - 09/2005
9Anemia
10/2014 - 07/2004
3Body Weight (Weight, Body)
01/2014 - 10/2007
3Diabetes Mellitus
10/2012 - 06/2009
3Hypertension (High Blood Pressure)
10/2012 - 09/2009
3Liver Failure
09/2012 - 01/2004
2Type 2 Diabetes Mellitus (MODY)
11/2013 - 06/2011
2Chronic Kidney Failure (Chronic Renal Failure)
03/2013 - 11/2011
2Thrombocytopenia (Thrombopenia)
02/2012 - 05/2009
2Kidney Diseases (Kidney Disease)
10/2011 - 01/2011
2Viremia
04/2010 - 01/2007
2Bone Fractures (Bone Fracture)
03/2010 - 07/2008
2Osteoporosis
03/2010 - 07/2008
2Jaundice
03/2005 - 01/2003
2Hemolytic Anemia
11/2004 - 07/2004
1Insulin Resistance
01/2015
1Hypophosphatemia
03/2014
1Stroke (Strokes)
01/2014
1Disease Progression
01/2014
1Renal Insufficiency (Renal Failure)
03/2013
1Hypoalbuminemia
06/2012
1Stomach Neoplasms (Stomach Cancer)
03/2012
1Fever (Fevers)
03/2012
1Anorexia
03/2012

Drug/Important Bio-Agent (IBA)

67InterferonsIBA
10/2015 - 01/2002
42AntigensIBA
04/2015 - 01/2002
41Lamivudine (3TC)FDA Link
06/2014 - 01/2002
39Ribavirin (Virazole)FDA LinkGeneric
02/2015 - 01/2002
33Hepatitis B e AntigensIBA
01/2015 - 01/2002
28DNA (Deoxyribonucleic Acid)IBA
01/2014 - 02/2002
26RNA (Ribonucleic Acid)IBA
10/2015 - 01/2003
18Alanine Transaminase (SGPT)IBA
07/2013 - 01/2003
15Hepatitis B Surface Antigens (HBsAg)FDA Link
03/2014 - 01/2002
11entecavirFDA Link
01/2014 - 06/2007
9telaprevirIBA
07/2015 - 01/2010
8adefovir dipivoxil (Hepsera)FDA Link
06/2014 - 01/2004
8alpha-Fetoproteins (AFP)IBA
01/2014 - 04/2006
7Non-alcoholic Fatty Liver DiseaseIBA
04/2015 - 01/2009
6lipoarabinomannan (LAM)IBA
04/2015 - 12/2007
6Interferon-betaIBA
01/2011 - 01/2008
5adefovirIBA
06/2014 - 01/2004
5miriplatinIBA
09/2013 - 01/2011
5BilirubinIBA
07/2013 - 01/2004
5Serum AlbuminIBA
06/2012 - 10/2007
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2012 - 08/2008
5gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2011 - 10/2007
4Protease Inhibitors (Protease Inhibitor)IBA
01/2014 - 01/2010
4Interferon-alpha (Interferon Alfa)FDA Link
12/2010 - 02/2002
4Aspartic Acid (Aspartate)FDA Link
04/2010 - 05/2004
3Antiviral Agents (Antivirals)IBA
02/2015 - 08/2012
3CreatinineIBA
03/2014 - 03/2013
3PlatinumIBA
03/2013 - 04/2009
3Hemoglobins (Hemoglobin)IBA
10/2012 - 11/2004
3Methionine (L-Methionine)FDA Link
04/2010 - 05/2004
3Tyrosine (L-Tyrosine)FDA Link
04/2010 - 05/2004
3Alanine (L-Alanine)FDA Link
01/2010 - 08/2004
2Guanosine Triphosphate (GTP)IBA
03/2014 - 01/2010
2Surface Antigens (Surface Antigen)IBA
01/2014 - 12/2002
2Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2014 - 03/2006
2sitagliptin (Januvia)FDA Link
11/2013 - 06/2011
2Cisplatin (Platino)FDA LinkGeneric
09/2013 - 03/2013
2Amino AcidsFDA Link
04/2013 - 02/2011
2EnzymesIBA
08/2012 - 01/2012
2Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2012 - 09/2008
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2010 - 04/2006
2TransferasesIBA
01/2005 - 08/2004
1Ritonavir (Norvir)FDA Link
10/2015
1HLA-DPB1 (HLA DPB1)IBA
04/2015
1HLA-DPA1 (HLA DPA1)IBA
04/2015
1HLA-DP Antigens (HLA-DP)IBA
04/2015
1peginterferon alfa-2a (Pegasys)FDA Link
01/2015
1Insulin (Novolin)FDA Link
01/2015
1tenofovir disoproxil (Viread)FDA Link
01/2014
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2014
1Dihydrotachysterol (AT 10)IBA
01/2014
1peginterferon alfa-2b (Pegintron)FDA Link
01/2014
1GadoliniumIBA
08/2013
1Pentetic Acid (DTPA)FDA LinkGeneric
08/2013
1HLA-DQB1 antigen (HLA DQB1)IBA
01/2013
1HLA-DQ Antigens (HLA-DQ)IBA
01/2013
1Prothrombin (Factor II)IBA
09/2012
1LDL CholesterolIBA
08/2012
1Glucose (Dextrose)FDA LinkGeneric
06/2012
1Ethiodized Oil (Ethiodol)FDA Link
03/2012
1Messenger RNA (mRNA)IBA
01/2012
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2012
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2012

Therapy/Procedure

5Drug Therapy (Chemotherapy)
09/2013 - 11/2011
4Retreatment
02/2015 - 01/2004